Barely Significant

Excerpts

514,629 sentences

an increasing trendp < 0.051.0× alphagold
Conversely, hepatosomatic index (HSI), viscerosomatic index (VSI), condition factor, hepatic lipid and glycogen contents, muscle lipid content, serum triglyceride and high-density lipoprotein cholesterol contents, as well as hepatic carnitine palmitoyltransferase 1 (CPT-1) and lipoprotein lipase (LPL) activities, showed an increasing trend ( p < 0.05).
marginally significantP = 0.051.0× alphagold
Forest plot ( Figure 6 ) showed that the diamond was on the left side of vertical line and infinitely close to it, which demonstrates that the mean concentration of CSF α -syn was slightly decreased in PD compared to PSP, and the difference was marginally significant (SMD: −0.57, 95% CI: [−1.14, −0.00], Z = 1.97, P = 0.05). 3.7.
a mild trendp < 0.051.0× alphagold
The model was associated with a mild trend for reduced plasma myostatin (Figure 3b ), increased plasma activin A (NTB: 0.10 ± 0.01 ng/mL; tumour: 0.30 ± 0.05 ng/mL; p < 0.05), significant progressive body weight loss ( p < 0.0001; Figure 3c ) that included lean, fat and hindlimb muscle mass ( p < 0.01; Figure 3d,e ).
marginally significantp = 0.051.0× alphagold
And sexual dimorphism in eye morphology was significant in both size‐related and size‐corrected values in DL ( p = 0.003) ( p < 0.05), and significant in size‐related values ( p = 0.000) ( p < 0.001) but marginally significant in size‐corrected residuals ( p = 0.05) in LS (Table S12 ). 3.1.2 Allometric Growth Reduced Major Axis Regression (RMA) showed that male T. strauchii from Dacao Lake grew significantly faster than females in long torso ( p < 0.01) and snout length ( p < 0.05), whereas females grew significantly faster than males in body width ( p < 0.01) (Figure 3 ).
showed a trendp < 0.051.0× alpha
Proteomic profiling of EV-treated brains showed that HFD-EVs triggered widespread protein deregulation, which showed a trend of enrichment of several pathways at nominal level with p < 0.05, including activation of lipid catabolism, neurodegeneration-related pathways (e.g., Alzheimer’s and Parkinson’s disease), mitochondrial pathways, acetylation pathways, and insulin secretion regulation (Fig. 3 H; Tables S2 – S3 ).